2017 Meeting Programme



10:00 – 10:30
Registration and morning coffee
10:30 – 10:35

Welcome and Introduction

Professor Neil Poulter, Imperial College London

10:35 – 11:10

CVD Prevention in T2DM

The Story so far (Before EMPA-REG)

Professor Neil Poulter, Imperial College London

 11:10 – 12:00

The SGLT2 and GLP1 Trials

Results of the macro vascular outcomes

Professor Naveed Sattar, University of Glasgow

 12:00 – 12:30

The DDP4- I Trials

What prospects for the class?

Professor Clifford J. Bailey, Aston University

 12:30 – 13:00

Hypoglycaemia and CVD

Professor Simon Heller, The University of Sheffield

 13:00 – 13:40



13:40 – 14:10

Renal outcomes and glucose lowering in recent trials

Professor John Wilding, University of Liverpool

14:10 – 14:40

Heart Failure and T2DM

Professor John G F Cleland, Glasgow University and Imperial College, London

14:40 – 15:10

Lipid-lowering for optimal CVD prevention

Professor Kausik Ray, Imperial College London

15:10 – 15:45

Breakout groups:

Groups will address one of four questions

A. Optimising secondary prevention of CV events by glucose-lowering in T2DM: The logistics (not the drugs)

B. Optimal BP management in T2DM/CKD/post CV events Targets/Thresholds/Drugs

C. When to refer to the following specialities:

  1. Diabetologist
  2. Hypertensionologist
  3. Lipidologist
  4. Renal physician/surgeon

D. Optimal drug sequencing for glucose lowering in T2DM

15:45 – 16:50

Table feedback from group discussion

16:50 – 17:00

Summary and meeting closure

17.00 – 18:00


Find out more

About the Meeting

We explored the latest techniques and developments in cardio-metabolic science.


The invited faculty delivered an innovative, comprehensive and educational programme.


The Meeting took place at Imperial College's Translation and Innovation Hub.